Jennifer Lynn Ziolkowski - Mar 3, 2025 Form 4 Insider Report for Vigil Neuroscience, Inc. (VIGL)

Role
Chief Financial Officer
Signature
/s/ Michael Cohen, Attorney-in-Fact
Stock symbol
VIGL
Transactions as of
Mar 3, 2025
Transactions value $
$0
Form type
4
Date filed
3/4/2025, 05:09 PM
Previous filing
May 7, 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIGL Stock Option Award (Right to Buy) Award $0 +156K $0.00 156K Mar 3, 2025 Common Stock 156K $2.19 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option award was issued pursuant to the Issuer's 2021 Stock Option and Incentive Plan and shall vest and become exercisable in forty-eight (48) equal monthly installments, with the first installment vesting on April 3, 2025.